168 related articles for article (PubMed ID: 16220750)
1. [Blood pressure control in hypertensive patients with stable coronary heart disease].
Chamontin B; Beaune J; Cambou JP; Vaisse B; Bonnelye G; Ricard S; Josse L; Gallois H
Arch Mal Coeur Vaiss; 2005; 98(7-8):795-9. PubMed ID: 16220750
[TBL] [Abstract][Full Text] [Related]
2. [Prevalence, treatment and control of hypertension in family practice patients in France during 1994].
Poggi L; Chamontin B; Lang T; Menard J; Chevalier H; Gallois H; Cremier O
Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1075-80. PubMed ID: 8949382
[TBL] [Abstract][Full Text] [Related]
3. [Hypertension management in general practice in Iceland].
Jensdóttir JO; Sigurethsson EL; Thornorgeirsson G
Laeknabladid; 2006 May; 92(5):375-80. PubMed ID: 16741320
[TBL] [Abstract][Full Text] [Related]
4. [Hypertension management in patients with stable coronary disease].
Amar J; Genès N; Vaur L; Charpentier G; Cambou JP; Guéret P
Arch Mal Coeur Vaiss; 2002; 95(7-8):657-60. PubMed ID: 12365075
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive efficacy of indapamide SR in hypertensive patients uncontrolled with a background therapy: the NATIVE study.
Akram J; Sheikh UE; Mahmood M; Donnelly R
Curr Med Res Opin; 2007 Dec; 23(12):2929-36. PubMed ID: 17931463
[TBL] [Abstract][Full Text] [Related]
6. [Management of severe hypertension in France in 1999 and 2000: intermediate results of a health insurance intervention program].
Tilly B; Guilhot J; Salanave B; Fender P; Allemand H
Arch Mal Coeur Vaiss; 2002; 95(7-8):687-94. PubMed ID: 12365081
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
8. Control of hypertension in Italy: results of the "Study on Antihypertensive Treatment in General Practice (STAP)". Physicians Taking Part in STAP.
Avanzini F; Alli C; Colombo P; Corsetti A; Colombo F; Tognoni G
G Ital Cardiol; 1998 Jul; 28(7):760-6. PubMed ID: 9773300
[TBL] [Abstract][Full Text] [Related]
9. [A comparison of the management of severe high blood pressure between 1999 and 2003 in France].
Bertin N; Salanave B; Tilly B; Guilhot J; Ricordeau P; Fender P; Dematons MN; Treppoz H; Allemand H
Arch Mal Coeur Vaiss; 2004; 97(7-8):793-8. PubMed ID: 15506068
[TBL] [Abstract][Full Text] [Related]
10. Treating hypertension by rational use of diuretics: results of the Russian ARGUS-2 Study.
Kobalava ZD; Kotovskaya YV; Villevalde SV; Moiseev VS;
Curr Med Res Opin; 2009 Sep; 25(9):2229-37. PubMed ID: 19622008
[TBL] [Abstract][Full Text] [Related]
11. [Aterial hypertension and cardiovascular risk factors associated with diabetes. Report of the PHARE survey in general practice].
Chamontin B; Lang T; Vaisse B; Nicodeme R; Antoine MP; Lazorthes ML; Gallois H; Poggi L
Arch Mal Coeur Vaiss; 2001 Aug; 94(8):869-73. PubMed ID: 11575221
[TBL] [Abstract][Full Text] [Related]
12. Blood pressure control in Italy: results of recent surveys on hypertension.
Volpe M; Tocci G; Trimarco B; Rosei EA; Borghi C; Ambrosioni E; Menotti A; Zanchetti A; Mancia G
J Hypertens; 2007 Jul; 25(7):1491-8. PubMed ID: 17563573
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
[TBL] [Abstract][Full Text] [Related]
14. Treatment of hypertension in Bahrain.
Al Khaja KA; Sequeira RP; Damanhori AH
Ann Pharmacother; 2003 Oct; 37(10):1511-7. PubMed ID: 14519051
[TBL] [Abstract][Full Text] [Related]
15. [Management of essential arterial hypertension and cardiovascular risk levels. Observation in general medicine: national PHENOMEN study. Evaluation and stratification of cardiovascular risk based on the 2000 ANAES recommendations in a population of hypertensive patients].
Mounier-Vehier C; Amah G; Covillard J; Jaboureck O; Phan TM
Arch Mal Coeur Vaiss; 2002; 95(7-8):667-72. PubMed ID: 12365077
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of the perindopril/indapamide combination therapy for hypertension: the PRIMUS study.
Holzgreve H; Risler T; Trenkwalder P
Curr Med Res Opin; 2006 Sep; 22(9):1849-58. PubMed ID: 16968588
[TBL] [Abstract][Full Text] [Related]
17. [Arterial hypertension management in patients with type 2 diabetes].
Charpentier G; Genès N; Vaur L; Clerson P; Amar J; Guéret P; Cambou JP
Arch Mal Coeur Vaiss; 2002; 95(7-8):661-5. PubMed ID: 12365076
[TBL] [Abstract][Full Text] [Related]
18. [Quality of blood pressure control in general practice and in the HOT study. French Research Group HOT (Hypertension Optimal Treatment)].
Raveau-Landon C
Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1179-81. PubMed ID: 8572869
[TBL] [Abstract][Full Text] [Related]
19. Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades.
Almgren T; Persson B; Wilhelmsen L; Rosengren A; Andersson OK
J Intern Med; 2005 Jun; 257(6):496-502. PubMed ID: 15910553
[TBL] [Abstract][Full Text] [Related]
20. Regular alcohol drinking is a determinant of masked morning hypertension detected by home blood pressure monitoring in medicated hypertensive patients with well-controlled clinic blood pressure: the Jichi Morning Hypertension Research (J-MORE) study.
Ishikawa J; Kario K; Eguchi K; Morinari M; Hoshide S; Ishikawa S; Shimada K;
Hypertens Res; 2006 Sep; 29(9):679-86. PubMed ID: 17249523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]